BRISBANE, Calif., May 1, 2019 /PRNewswire/ -- Sangamo
Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company,
announced today that the Company will release its first quarter
2019 financial results after the market closes on Wednesday, May 8, 2019. The press release will be
followed by a conference call at 5:00 p.m.
ET, which will be open to the public via telephone and
webcast. During the conference call, the Company will review its
financial results and provide a business update.
The conference call dial-in numbers are (877) 377-7553 for
domestic callers and (678) 894-3968 for international callers. The
conference ID number for the call is 7577586. Participants may
access the live webcast via a link on the Sangamo Therapeutics
website in the Investors and Media section under Events and
Presentations. A conference call replay will be available for one
week following the conference call. The conference call replay
numbers for domestic and international callers are (855) 859-2056
and (404) 537-3406, respectively. The conference ID number for the
replay is 7577586.
About Sangamo Therapeutics
Sangamo Therapeutics,
Inc. is focused on translating ground-breaking science into
genomic medicines with the potential to transform patients' lives
using gene therapy, ex vivo gene-edited
cell therapy, in vivo genome editing, and
gene regulation. For more information about Sangamo,
visit www.sangamo.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-first-quarter-2019-conference-call-and-webcast-300842121.html
SOURCE Sangamo Therapeutics, Inc.